From Nasdaq

May 14, 2025 6:44:00 pm:

Today’s Zacks Research Daily features new reports on major stocks like Oracle Corp. (ORCL), IBM Corp. (IBM), Merck & Co., Inc. (MRK), and Earth Science Tech, Inc. (ETST). Oracle is seeing growth in its cloud business, while IBM is benefiting from strong demand for hybrid cloud and AI. Merck is facing competitive pressures, while Earth Science Tech is showing strong revenue growth.

Oracle’s shares have outperformed the Zacks Computer – Software industry, driven by cloud momentum and partnerships, with fiscal 2025 net sales expected to grow by 7.7%. IBM’s shares have also outperformed the Zacks Computer – Integrated Systems industry, with growth expected in analytics, cloud computing, and security. Merck’s shares have underperformed the Zacks Large Cap Pharmaceuticals industry, but it is seeing growth in Keytruda sales. Earth Science Tech has outperformed the Zacks Medical – Biomedical and Genetics industry with strong revenue growth.

The Zacks Research Daily also features other reports on stocks like CVS Health Corporation (CVS), MetLife, Inc. (MET), and Coinbase Global, Inc. (COIN). CVS Health is seeing solid revenue gains in Healthcare Delivery, while MetLife is benefiting from acquisitions and cost-cutting initiatives. Coinbase is expected to see improving revenues but faces challenges from escalating expenses. Other reports include Yum! Brands (YUM), M&T Bank (MTB), and Wabtec (WAB).

Additionally, Zacks’ Research Chief has identified the “Stock Most Likely to Double”, highlighting an innovative financial firm poised for significant gains. The report also offers insights into 5 stocks with the greatest probability of gaining over 100% in the coming months. Check out the latest recommendations from Zacks Investment Research for free.

Read more at Nasdaq: Top Analyst Reports for Oracle, IBM & Merck